FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.

Dr. Scott Cyrus offers expert insights into asthma, including common symptoms, effective treatments, and management strategies to improve the quality of life for those affected by the condition.

Part of me didn’t want to believe that he was talking about my tiny baby, the one lying in an incubator. Back in 2008, Spike ...

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

They include fever, dry cough, sore throat, congested nose and, in severe cases, rapid or difficult breathing. However, one key difference is that RSV frequently causes wheezing, which is less ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, hospitalizations, lost quality of life, and deaths, according to one study.

RSV can cause lung infections including pneumonia and infant bronchitis and accounts for around 40,000 hospitalisations in the UK and between 20 and 30 infant deaths every year. It is believed ...

All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...

Pregnant women across Australia could be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next year. Health Minister Mark Butler has flagged the ...

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.